Literature DB >> 21420244

Magnetic resonance imaging in postprostatectomy radiotherapy planning.

Jana Sefrova1, Karel Odrazka, Petr Paluska, Zdenek Belobradek, Milos Brodak, Martin Dolezel, Petr Prosvic, Zuzana Macingova, Milan Vosmik, Petr Hoffmann, Miroslav Louda, Anna Nejedla.   

Abstract

PURPOSE: To investigate whether the use of magnetic resonance imaging (MRI) in prostate bed treatment planning could influence definition of the clinical target volume (CTV) and organs at risk. METHODS AND MATERIALS: A total of 21 consecutive patients referred for prostate bed radiotherapy were included in the present retrospective study. The CTV was delineated according to the European Organization for Research and Treatment of Cancer recommendations on computed tomography (CT) and T(1)-weighted (T(1)w) and T(2)-weighted (T(2)w) MRI. The CTV magnitude, agreement, and spatial differences were evaluated on the planning CT scan after registration with the MRI scans.
RESULTS: The CTV was significantly reduced on the T(1)w and T(2)w MRI scans (13% and 9%, respectively) compared with the CT scans. The urinary bladder was drawn smaller on the CT scans and the rectum was smaller on the MRI scans. On T(1)w MRI, the rectum and urinary bladder were delineated larger than on T(2)w MRI. Minimal agreement was observed between the CT and T(2)w images. The main spatial differences were measured in the superior and superolateral directions in which the CTV on the MRI scans was 1.8-2.9 mm smaller. In the posterior and inferior border, no difference was seen between the CT and T(1)w MRI scans. On the T(2)w MRI scans, the CTV was larger in these directions (by 1.3 and 1.7 mm, respectively).
CONCLUSIONS: The use of MRI in postprostatectomy radiotherapy planning resulted in a reduction of the CTV. The main differences were found in the superior part of the prostate bed. We believe T(2)w MRI enables more precise definition of prostate bed CTV than conventional planning CT.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21420244     DOI: 10.1016/j.ijrobp.2010.11.004

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  7 in total

1.  The influence of MRI scan position on image registration accuracy, target delineation and calculated dose in prostatic radiotherapy.

Authors:  S Hanvey; A H Sadozye; M McJury; M Glegg; J Foster
Journal:  Br J Radiol       Date:  2012-12       Impact factor: 3.039

2.  Volumetric image-guided highly conformal radiotherapy of the prostate bed: Toxicity analysis.

Authors:  Gianluca Ingrosso; Alessandra Carosi; Daniela di Cristino; Elisabetta Ponti; Andrea Lancia; Alessandra Murgia; Claudia Bruni; Pasquale Morelli; Franca Pietrasanta; Riccardo Santoni
Journal:  Rep Pract Oncol Radiother       Date:  2016-11-24

3.  Dynamic contrast-enhanced MRI for automatic detection of foci of residual or recurrent disease after prostatectomy.

Authors:  N Andres Parra; Amber Orman; Kyle Padgett; Victor Casillas; Sanoj Punnen; Matthew Abramowitz; Alan Pollack; Radka Stoyanova
Journal:  Strahlenther Onkol       Date:  2016-10-19       Impact factor: 3.621

Review 4.  ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II.

Authors:  Nicholas G Zaorsky; Timothy N Showalter; Gary A Ezzell; Paul L Nguyen; Dean G Assimos; Anthony V D'Amico; Alexander R Gottschalk; Gary S Gustafson; Sameer R Keole; Stanley L Liauw; Shane Lloyd; Patrick W McLaughlin; Benjamin Movsas; Bradley R Prestidge; Al V Taira; Neha Vapiwala; Brian J Davis
Journal:  Adv Radiat Oncol       Date:  2016-10-20

5.  Volumetry of the dominant intraprostatic tumour lesion: intersequence and interobserver differences on multiparametric MRI.

Authors:  Hugh Harvey; Matthew R Orton; Veronica A Morgan; Chris Parker; David Dearnaley; Cyril Fisher; Nandita M deSouza
Journal:  Br J Radiol       Date:  2017-01-05       Impact factor: 3.039

6.  The influence of MRI scan position on patients with oropharyngeal cancer undergoing radical radiotherapy.

Authors:  Scott Hanvey; Mark McJury; Lye Mun Tho; Martin Glegg; Maureen Thomson; Derek Grose; Allan James; Mohammed Rizwanullah; Claire Paterson; John Foster
Journal:  Radiat Oncol       Date:  2013-05-28       Impact factor: 3.481

Review 7.  Multiparametric MRI for recurrent prostate cancer post radical prostatectomy and postradiation therapy.

Authors:  Flavio Barchetti; Valeria Panebianco
Journal:  Biomed Res Int       Date:  2014-05-25       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.